|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| (11) | Number of the document | 4220360 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23152543.7 |
| Date of filing the European patent application | 2016-11-11 | |
| (97) | Date of publication of the European application | 2023-08-02 |
| (45) | Date of publication and mention of the grant of the patent | 2024-06-26 |
| (46) | Date of publication of the claims translation | 2024-09-10 |
| (30) | Number | Date | Country code |
| 15194367 | 2015-11-12 | EP | |
| 16189502 | 2016-09-19 | EP |
| (72) |
COSTA, Veronica , CH
HEDTJÄRN, Maj , DK
HOENER, Marius , CH
JAGASIA, Ravi , CH
JENSEN, Mads Aaboe , DK
PATSCH, Christoph , DE
PEDERSEN, Lykke , DK
RASMUSSEN, Søren Vestergaard , DK
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Oligonukleotidai, indukuojantys tėvinės UBE3A raišką |
| OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 10 | 231.00 EUR |
| 2026-11-11 |